HER2 Exon 20 Insertion Mutations in Lung Adenocarcinoma: Case Series and Response to Pyrotinib.

导出 LinkOut

翻译打印收藏纠错

作者： Xinyong,Zhang ^[1] ; Jialin,Lv ^[1] ; Yuhua,Wu ^[1] ; Na,Qin ^[1] ; Li,Ma ^[1] ; Xi,Li ^[1] ; Jingying,Nong ^[1] ; Hui,Zhang ^[1] ; Quan,Zhang ^[1] ; Xinjie,Yang ^[1] ; Huibo,Shi ^[2] ; Jinghui,Wang ^[1] ; Shucai,Zhang ^[1]

作者单位： Department of Medical Oncology, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China. ^[1] Organ Transplantation Research Institute, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. ^[2]

关键词 driver oncogenes exon 20 human epidermal growth factor receptor 2 lung adenocarcinoma pyrotinib

DOI 10.3389/fonc.2020.01162

PMID 32850330

发布时间 2020-09-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Frontiers in oncology

2020年10卷

1162页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

HER2 Exon 20 Insertion Mutations in Lung Adenocarcinoma: Case Series and Response to Pyrotinib.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

HER2 Exon 20 Insertion Mutations in Lung Adenocarcinoma: Case Series and Response to Pyrotinib.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除